Dataset
Amisulpride; LC-ESI-Q; MS; POS; 45 V
Chemical Information
| InChI | InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21) |
|---|---|
| SMILES | CCN(C2)C(CC2)CNC(=O)c(c(OC)1)cc(c(N)c1)S(=O)(=O)CC |
| InChI Key | NTJOBXMMWNYJFB-UHFFFAOYSA-N |
| Molecular Formula | C17H27N3O4S |
| Exact Mass | 369.172 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-nc/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA001177 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| AMISULPRIDE | rxnorm |
| DAN-2163 | clinicaltrials |
| BARHEMSYS | clinicaltrials |
| AMISULPRIDE | clinicaltrials |
| SOLIAN | clinicaltrials |
| APD-421 | clinicaltrials |
| APD421 | clinicaltrials |
| HY-14545 | MedChemExpress |
| 8110R61I4U | FDA SRS |
| DTXSID5042613 | EPA CompTox Dashboard |
| 179 | DrugCentral |
| J18.603A | Nikkaji |
| 81790 | BindingDB |
| AMISULPRIDE | DailyMed |
| BARHEMSYS | rxnorm |
| 64045 | ChEBI |
| HMDB0015633 | Human Metabolome Database |
| DB06288 | DrugBank |
| 12013930 | PubChem: Drugs of the Future |
| CHEMBL243712 | ChEMBL |
| SAM001246639 | NIH Clinical Collection |
| 963 | Guide to Pharmacology |
| CB7312326 | ChemicalBook |
| MCULE-4239265090 | Mcule |
| SCHEMBL34126 | SureChEMBL |
| 71675-85-9 | ACToR |
| 2159 | PubChem |
| PD001316 | ProbesDrugs |
| LSM-1669 | LINCS |
| 14852985 | PubChem: Thomson Pharma |
| Amisulpride | Selleck |
| PA162565877 | PharmGKB |
| 1985473 | eMolecules |
| The data in this table is sourced from UniChem at EBI. | |